Growth predictors and prognosis of small abdominal aortic aneurysms

被引:122
作者
Schlosser, Felix J. V. [1 ,2 ]
Tangelder, Marco J. D. [1 ]
Verhagen, Hence J. M. [3 ]
van der Heijden, Geert J. M. G. [2 ]
Muhs, Bart E. [4 ]
van der Graaf, Yolanda [2 ]
Moll, Frans L. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Vasc Surg, NL-3508 GA Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[3] Erasmus Univ, Med Ctr, Dept Vasc Surg, Rotterdam, Netherlands
[4] Yale Univ, Sch Med, Vasc Surg Sect, New Haven, CT USA
关键词
D O I
10.1016/j.jvs.2008.01.041
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: Evidence regarding the influence of cardiovascular risk factors, comorbidities, and patient characteristics on the growth of small abdominal aortic aneurysms (AAA) is limited. We assessed, in an observational cohort study, rupture rates, risks of mortality, and the effects of cardiovascular risk factors and patient demographics on growth rates of small AAAs. Methods: Between September 1996 and January 2005, 5057 patients with manifest arterial vascular disease or cardiovascular risk factors were included in the Second Manifestation of ARTerial disease (SMART) study. Measurements of the abdominal aortic diameter were performed in all patients. All patients with an initial AAA diameter between 30 and 55 mm were selected for this study. All AAA measurements during follow-up until August 2007 were collected. Multivariate regression analysis was performed to calculate the effects of demographic patient characteristics, initial AAA diameter, and cardiovascular risk factors on AAA growth. Results: Included were 230 patients, with a mean age of 66 years and 90% were male. Seven AAA ruptures (six fatal) occurred in 755 patient years of follow-up (rupture rate 0.9% per patient-year). In 147 patients, AAA measurements were performed for a period of more than 6 months. The median follow-up time was 3.3 years (mean 4.0, range 0.5 to 11.1 years, standard deviation (SD) 2.5). Mean AAA diameter was 38.8 mm (SD 6.8) and mean expansion rate 2.5 mm/y. Patients using lipid-lowering drugs had a 1.2 mm/y (95% confidence interval [CI] -2.34 to -0.060 mm/y) lower AAA growth rate compared to nonusers of these drugs. Initial AAA diameter was associated with a 0.09 mm/y (95% CI 0.01 to 0.18 mm/y) higher growth rate per millimetre increase of the diameter. No other factors, including blood lipid values, were independently associated with AAA growth. Conclusions: Lipid-lowering drug treatment and initial AAA diameter appear to be independently associated with lower AAA growth rates. The risk of rupture of these small abdominal aortic aneurysms was low, which pleads for watchful waiting.
引用
收藏
页码:1127 / 1133
页数:7
相关论文
共 32 条
[1]   Ten-year outcome of patients with very small abdominal aortic aneurysm [J].
Biancari, F ;
Mosorin, M ;
Anttila, V ;
Satta, J ;
Juvonen, J ;
Juvonen, T .
AMERICAN JOURNAL OF SURGERY, 2002, 183 (01) :53-55
[2]   Abdominal aortic aneurysm expansion - Risk factors and time intervals for surveillance [J].
Brady, AR ;
Thompson, SG ;
Fowkes, FGR ;
Greenhalgh, RM ;
Powell, JT .
CIRCULATION, 2004, 110 (01) :16-21
[3]   Selective management of abdominal aortic aneurysms smaller than 5.0 cm in a prospective sizing program with gender-specific analysis [J].
Brown, PM ;
Sobolev, B ;
Zelt, DT .
JOURNAL OF VASCULAR SURGERY, 2003, 38 (04) :762-765
[4]   Risk factors associated with rapid growth of small abdominal aortic aneurysms [J].
Chang, JB ;
Stein, TA ;
Liu, JP ;
Dunn, ME .
SURGERY, 1997, 121 (02) :117-122
[5]  
DEVEGA CM, 2006, EUR J VASC ENDOVASC, V31, P231
[6]   Genetic approach to the role of cysteine proteases in the expansion of abdominal aortic aneurysms [J].
Eriksson, P ;
Jones, KG ;
Brown, LC ;
Greenhalgh, RM ;
Hamsten, A ;
Powell, JT .
BRITISH JOURNAL OF SURGERY, 2004, 91 (01) :86-89
[7]   Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue [J].
Evans, J. ;
Powell, J. T. ;
Schwalbe, E. ;
Loftus, I. M. ;
Thompson, M. M. .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2007, 34 (03) :302-303
[8]   ABDOMINAL AORTIC-ANEURYSM EXPANSION RATE - EFFECT OF SIZE AND BETA-ADRENERGIC-BLOCKADE [J].
GADOWSKI, GR ;
PILCHER, DB ;
RICCI, MA .
JOURNAL OF VASCULAR SURGERY, 1994, 19 (04) :727-731
[9]   LDL cholesterol is associated with small abdominal aortic aneurysms [J].
Hobbs, SD ;
Claridge, MWC ;
Quick, CRG ;
Day, NE ;
Bradbury, AW ;
Wilmink, ABM .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2003, 26 (06) :618-622
[10]   Simvastatin suppresses experimental aortic aneurysm expansion [J].
Kalyanasundaram, A ;
Elmore, JR ;
Manazer, JR ;
Golden, A ;
Franklin, DP ;
Galt, SW ;
Zakhary, EMA ;
Carey, DJ .
JOURNAL OF VASCULAR SURGERY, 2006, 43 (01) :117-124